MERCK
CANINE ADENOVIRUS TYPE 2-PARAINFLUENZA-BORDETELLA BRONCHISEPTICA VACCINE
Modified Live Virus and Avirulent Live Culture
FOR ANIMAL USE ONLY
NobivacŪ Intra-TracŪ3 vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough. Duration of Immunity (DOI) has been demonstrated to be at least one year for Bordetella bronchiseptica.
DOSAGE AND ADMINISTRATION: Vaccinate dogs at 3 weeks of age or older. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships. Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com
|